This site is intended for Healthcare professionals only.

Ascending aortic aneurysm: Are they amenable to endovascular treatment? -Dr NN Khanna


Ascending aortic aneurysm: Are they amenable to endovascular treatment? -Dr NN Khanna

Global Burden Disease 2010 project demonstrated that the overall global death rate from aortic aneurysms and AD increased from 2.49 per 100 000 to 2.78 per 100 000 inhabitants between 1990 and 2010, with higher rates for men. Endovascular therapies are playing an increasingly important role in the treatment of aortic diseases, while surgery remains necessary in many situations.

Several reasons made the endovascular approach is challenging: (1) Lack of adequate endograft landing zones. Stent-grafts should fixate and seal proximally just distal to the sinotubular junction; (2) Distal sealing should be obtained just proximal to the innominate artery, requiring thus a short stent-graft length (50–80 mm); (3) Migration forces in the ascending aorta are greater in comparison to stent-grafts placed more distally in the aorta (descending and abdominal); (4) Diameters of the ascenden portion are larger compared to the descending aorta (5) Stent-graft delivery may require working within the left ventricle, through the aortic valve, with additional technical difficulties and operative risks. In addition, length of current thoracic endovascular stents is a potential issue because the ascending aorta is close to the coronary ostia and the brachiocephalic vessels.

There are several pathologies of the ascending aorta that can be potentially addressed by the endovascular approach. Pseudoaneurysms or saccular aneurysms in the mid-ascending aorta are adequate for this technique because they usually appear with a sufficient proximal and distal landing zone. On the other hand, fusiform aneurysms have the limitation of lacking a sufficient landing zone in many cases.

Dr. (Prof.) NN Khanna  Sr. Consultant Interventional Cardiology & Vascular Interventions and Coordinator – Vascular Services Indraprastha Apollo Hospitals is presenting  on three topics at India Live 2018

 

The following two tabs change content below.
Anjali Nimesh

Anjali Nimesh

Anjali Nimesh Joined Medical Dialogue as Reporter in 2016. she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Dr. Bhimrao Ambedkar University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Source: self

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted